July 20 (Reuters) - Australia's competition watchdog on Thursday raised concerns over Australian Clinical Labs' (ACL) A$1.52 billion ($1.03 billion) buyout offer for medical centre operator Healius (HLS) , who had rejected the proposal in May.
The Australian Competition and Consumer Commission said the acquisition would lessen competition in the Australian pathology services markets.
($1 = 1.4775 Australian dollars)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
79.3¢ |
Change
-0.023(2.76%) |
Mkt cap ! $577.2M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 82.5¢ | 78.8¢ | $2.089M | 2.600M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 74601 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.5¢ | 52979 | 24 |
View Market Depth
| Last trade - 12.51pm 13/08/2025 (20 minute delay) ? |
| HLS (ASX) Chart |